control transformations produced multiple colonies, each representing an independent stably transformed line, that could be directly and quantitatively compared to colonies derived from test transformations. Comparisons were based on the percentage of stably transformed lines that produced gametophores and on gametophore morphology. A dissecting microscope (Meiji EMZ-TR, Meiji Techno Co. Ltd., Tokyo, Japan) was used at 30 × to count the number of lines with and without gametophores. Colonies and individual gametophores were photographed using a stereomicroscope (Leica M165 FC with Leica BFC310 FX camera, Leica Microsystems, Buffalo Grove, Illinois, USA), and individual leaves were photographed using a compound microscope (Olympus BX51, Olympus Corporation, Lake Success, New York, USA) with a Spot Flex camera (Diagnostic Instruments, Sterling Heights, Michigan, USA). The positive control CESA5 vector complemented the ppcesa5 KO-2 phenotype, with 78% ± 3.8% of lines (average for seven independent transformations: 138 stably transformed lines) producing gametophores that generally resembled wild-type gametophores ( Fig. 1A ) . When ppcesa5 KO-2 was transformed with the empty negative control vector, only 13% ± 4.9% of lines (average for seven independent transformations: 182 stably transformed lines) produced gametophores. These were distinctly abnormal with fewer than 10 small misshapen leaves and abnormal phyllotaxy ( Fig. 1A ) and resembled those that are produced at low frequency by the untransformed ppcesa5 KO-2 line ( Goss et al., 2012 ) . Fewer than 10% of stable lines produced gametophores in a typical negative control transformation, and even when the percentage was higher the gametophores were never normal in appearance. To ensure consistency, colonies were scored for presence and absence of gametophores without considering gametophore morphology. Statistical analysis (see below) confi rmed that this was adequate for distinguishing test vectors that complemented or failed to complement the mutant phenotype. However, deviations from expected morphologies were recorded, and this information was used to identify vectors that partially complemented the mutant phenotype (see below).
We tested the complementation assay with expression vectors carrying the PpCESA5 coding sequence with three different point mutations at R453 ( Table 1 ) . The R453K mutation is homologous to fra6 , a recessive mutation in A. thaliana ( AtCESA8 , R362K) that results in decreased fi ber wall thickness and cellulose content, but has a less severe phenotype compared to other atcesa8 mutant alleles ( Zhong et al., 2003 ) . Although AtCESA8 expression is correlated with secondary cell wall deposition and fra6 is defective in fi ber development, the affected residue is conserved ( Zhong et al., 2003 ) . Thus, the phenotypes for homologous mutations in different CESA genes would be expected to depend on the developmental function of the mutated CESA. When the ppcesa5 KO-2 line was transformed with the R453K expression vector, the percentage of stable lines producing gametophores was intermediate between the positive and negative control and gametophore morphology was similar to wild type ( Fig. 1 ) . When the basic polar R453 residue was instead replaced with an acidic polar D residue (R453D), all stable lines lacked gametophores ( Fig. 1 ) . Finally, replacement of R453 with a nonpolar G residue (R453G) yielded results similar to the positive control for both percentage of stable lines with gametophores and gametophore morphology ( Fig. 1 ) .
Statistics and experimental analysis -A two-tailed Fisher's exact test of independence ( Sokal and Rohlf, 1981 ) was used for statistical analysis of complementation. Statistics were calculated using the 2 × 2 contingency table at http://vassarstats.net/tab2x2.html and sample calculations were verifi ed manually. We fi rst confi rmed that the numbers of colonies with and without gametophores were signifi cantly different for the CESA5 positive control and the empty negative control vectors ( P < 0.0001, pooled results from seven experiments). Comparison of each test vector to the positive and negative controls using counts pooled from two or three transformations ( Fig. 1B ) showed that R453K and R453D differed signifi cantly from the positive control ( P < 0.0001), but not the empty negative control vector ( P = 0.27 and P = 0.50, respectively). In contrast, R453G differed signifi cantly from the negative control ( P < 0.0001), but not the CESA5 positive control vector ( P = 0.14). Although R453K did not differ signifi cantly from the negative control vector in the numbers of colonies with and without gametophores, the gametophores that were produced resembled those observed following transformation with the CESA5 positive control vector ( Fig. 1A ) , indicating that the encoded protein may be partially functional. The vectors tested fall into three classes (1) R453G fully complements, (2) R453D does not complement, and (3) R453K partially complements the cesa5 KO-2 phenotype. Thus, this relatively rapid assay allows us to screen mutations and tentatively identify those that generate functional, nonfunctional, and partially functional proteins. Because these three classes of mutations could be distinguished based on statistical comparison to positive and negative controls, we were able to streamline the assay by not genotyping the the wild-type PpCESA5 protein, these lines produces normal gametophores ( Goss et al., 2012 ) . This provides a platform for developing a complementation assay to test CESA proteins that have been modifi ed by site-directed mutagenesis with the extent of rescue of the mutant phenotype providing a measure of protein function.
Here we describe a complementation assay in P. patens for analysis of structure/function relationships in plant CESA proteins that is rapid and has modest space requirements. Although designed for analysis of CESA proteins, this assay could be adapted to study structure/function relationships of other proteins where the knockout phenotype can be easily scored.
METHODS AND RESULTS
Vector construction and ppcesa5 KO-2 transformation -Expression vectors carrying a wild-type (positive control) or a mutated (test) PpCESA5 coding sequence fused at the N-terminus to a triple hemagglutinin (3XHA) epitope tag were constructed using PCR fusion and MultiSite Gateway cloning ( Atanassov et al., 2009 ) . To create Gateway entry clones carrying point mutations, gene fragments were amplifi ed from wild-type PpCESA5 cDNA clone pdp24095 (RIKEN BioResource Center, http://www.brc.riken.jp/lab/epd/Eng/) using primer pairs that added an att site at one end and introduced a mutation at the other (Appendix 1; Appendix 2, Fig. A1, A2 ). The fragments were fused in a single overlap extension reaction (Appendix 2) and cloned into pDONR 221 P5-P2 according to the manufacturer's instructions (Life Technologies, Grand Island, New York, USA). CESA5 entry clones were sequence verifi ed using primers listed in Appendix 3. To create the 3XHA entry clone, two oligonucleotides (Appendix 1) were fused, cloned into pDONR 221 P1-P5r (Life Technologies), and sequence verifi ed using primer M13 Forward (−20) (Life Technologies). Each CESA5 entry clone was transferred along with a 3XHA entry clone to the pTHAct1Gate destination vector using LR Clonase II Plus as described by the manufacturer (Life Technologies). The pTHAct1Gate vector contains an Act1 promoter from rice, which drives constitutive expression in P. patens , and sequences that target the vector to the P. patens 108 locus, which can be disrupted without producing a phenotype ( Perroud and Quatrano, 2006 ) .
Protoplasts prepared from mutant P. patens line ppcesa5 KO-2 ( Goss et al., 2012 ) were divided into fi ve or six samples (6 × 10 5 protoplasts each) and each sample was transformed with a test (R453K, R453D, or R453G), positive wildtype CESA5 expression, or empty pTHAct1 negative control vector ( Table 1 ) , following the detailed protocol of Roberts et al. (2011) . Regenerated protoplasts were subjected to two rounds of selection , which typically resulted in 10-40 vigorously growing, stably transformed lines for each vector (Appendix 2, Fig. A3 ). Results from an experiment (i.e., fi ve to six transformations using the same batch of protoplasts) were excluded from the statistical analysis when fewer than 10 lines were obtained for the positive or negative control transformations. In cases where one or more test vectors from an otherwise successful experiment yielded fewer than 10 lines, results from only those test vectors were excluded. Isolated colonies, each comprising an independent stably transformed line, were arrayed on solid BCDAT plates and incubated in a growth chamber at 25 ° C with fl uorescent lights at a photon fl ux density of 60 μ M m −2 s −1 for 7 d.
Complementation analysis -To make the assay as rapid as possible, we evaluated phenotypes using primary colonies derived from independently transformed protoplasts and selected for stable antibiotic resistance. In contrast to tissue subcultured from wild-type and mutant lines, the positive and negative ( Fig. 2 ) . These results rule out lack of expression as an explanation for the failure of the R453D protein to complement the mutant phenotype. Thus, it can be concluded that, in contrast to the wild-type CESA5 and R453G proteins, the R453D protein is nonfunctional. Because (1) transgenic protein is strongly expressed in a high proportion of stably transformed lines and (2) the wild-type CESA5 protein complements the mutant phenotype over a range of protein expression levels, detailed quantitative analysis of protein expression is not required for detection of mutations that impair protein function.
Comparison to other methods -Complementation assays provide means to test hypotheses about the functions of specifi c proteins and protein modifi cations and are particularly useful when a robust in vitro assay is not available, as is the case for CESA proteins ( Guerriero et al., 2010 ) . Arabidopsis thaliana has been used previously for genetic analysis of engineered CESA variants ( Wang et al., 2006 ; Chen et al., 2010 ; Bischoff et al., 2011 ; Slabaugh et al., 2014b ) . However, P. patens has the advantages that transformation, selection, and scoring can be completed in 33 d and less space is required to maintain cultures. In A. thaliana , production of transformants requires three months ( Zhang et al., 2006 ) , with additional time needed for backcrossing to obtain homozygous lines. Because the dominant phase of the P. patens life cycle is haploid, backcrossing in unnecessary.
In P. patens , an assay has been developed for using image analysis to screen for mutants that affect protonemal growth and to test for transient complementation of those phenotypes ( Bibeau and Vidali, 2014 ) . In contrast to this highly sensitive assay for detecting protonemal growth defects, the assay reported here is suitable for analysis of proteins involved in other aspects of P. patens development. It is common practice to use complementation analysis to verify knockout phenotypes in P. patens , and cross-species complementation has been used to test for functional conservation of vascular plant and P. patens proteins (e.g., Bravo-Garcia et al., 2009 ). Here we have described a systematic approach for quantitative analysis of complementation based on comparison to positive and negative controls that can be used for functional testing of heterologous genes, as well as engineered mutations.
An effective complementation assay is based on a mutant with a measurable phenotype that is easy to score. The absence of normal gametophores in the ppcesa5 KO mutants ( Goss et al., 2012 ) is readily observed with a dissecting stable transformants. The failure of gametophore production in 12-39% of the stable lines from transformation with the positive control CESA5 vector can potentially be explained by (1) disruption of the promoter or coding sequence of the vector during integration, which would result in lack of transgene expression, or (2) disruption of another locus that is necessary for gametophore development due to mistargeting of the vector, which would explain lack of complementation when protein expression is detected (see below). This is supported by the observation that transformation of P. patens with a gene disruption library resulted in a high proportion of lines with gametophore defects ( Egener et al., 2002 ) . These mistargeting events are stochastic ( Kamisugi et al., 2006 ) , and statistical analysis confi rms that they do not interfere with the ability to distinguish complementing from noncomplementing vectors and partially complementing vectors.
Protein determination -Before concluding that a specifi c mutation impairs the function of an encoded protein, it is necessary to rule out lack of expression of the full-length transgenic protein as an explanation for failure of the vector to complement the mutant phenotype. This was tested by Western blot analysis of microsomal proteins isolated from arbitrarily selected stable lines representing a small proportion of lines tested for complementation (see Appendix 2 for protein extraction methods). Equal masses of protein extracted from 13 stable CESA5 positive control lines, or 12 stable lines transformed with a particular test vector along with one CESA5 positive control line, were separated by polyacrylamide gel electrophoresis (PAGE) and transferred to membranes for total protein detection with Ponceau S and immuno-detection of hemagglutinin (HA)-tagged protein as described in Appendix 2. As shown in Fig. 2 , we tested different protein loadings and found that 7 μ g per lane was suffi cient for detecting expression of the transgenic protein. Of 13 CESA5 positive control lines tested, 11 produced an HA-tagged protein with the expected molecular mass of 122 kDa ( Fig. 2 ) . The two lines in which the transgenic protein was not detected failed to produce gametophores ( Fig. 2 ) . However, two lines that expressed the full-length protein also failed to produce gametophores, possibly due to mistargeting of the expression vector to a separate locus required for gametophore development. These data also show that successful complementation occurs over a range of protein expression levels. Full-length transgenic protein was detected in 11 of the 12 lines transformed with R453G or R453K. As noted for CESA5, transgenic protein was undetectable in some, but not all, of the lines that failed to produce gametophores ( Fig. 2 ) . Although none of the stable lines allowing classifi cation of engineered proteins as either fully functional, partially functional, or nonfunctional, (3) engineering of genes through PCR fusion without introduction of restriction or recombination sites, (4) epitope-tagging to facilitate testing for expression of full-length transgenic protein through Western blotting, and (5) microscope. Scoring for presence or absence of gametophores, combined with statistical analysis comparing test vectors to a positive control vector that drives expression of the wild-type gene and an empty negative control vector, enabled us to discriminate between test vectors that complement and fail to complement the mutant phenotype. The assay also allows detection of mutations that generate partially functional proteins as exemplifi ed by ppcesa5R453K . The homologous fra6 mutation in A. thaliana is a partial loss-of-function mutation ( Zhong et al., 2003 ) , indicating that results from P. patens can be translated to vascular plants. Gene variants that exhibit partial complementation may be of special interest and can be further characterized in P. patens or A. thaliana . The use of PCR fusion combined with Gateway cloning (Life Technologies) enables rapid construction of vectors that drive expression of proteins with point mutations, insertions, deletions, or chimeric sequences without added recombination or restriction sites ( Atanassov et al., 2009 ) . The ability to test expression and molecular mass of the transgenic protein by Western blotting is an essential component of the assay that was facilitated by epitope tagging. However, detailed analysis of protein expression levels is unnecessary due to consistently high transgenic protein expression along with successful complementation over a range of wild-type CESA5 protein expression levels. Although we designed this assay for functional testing of genes that encode CESA proteins, the approach could be adapted for any P. patens gene with a mutant phenotype that can be easily scored.
CONCLUSIONS
In summary, the strengths of this complementation assay include (1) a clear phenotype that can be easily scored, (2) inclusion of positive and negative controls and statistical analysis Primer Sequence primers that include an engineered mutation with about 12 nucleotides upstream and downstream of the mutation (Appendix 1, Fig. A1 ) . 2. Amplify fragments F1 and F2 ( Fig. A1 ) in 50-μ L reactions using Phusion DNA polymerase (M0530S, New England Biolabs, Ipswich, Massachusetts, USA) and recommended cycling conditions. We used a 25-s annealing step at 68 ° C, but this may need to be adjusted depending on the primers used.
Fig. A1.
A schematic of site-directed mutagenesis through PCR fusion. Fragments F1 and F2 of the gene of interest are amplifi ed using the primers attB5 and SR1 and attB2 and SF1, respectively. Fragments F1 and F2 are combined in a single-cycle PCR fusion reaction to create the mutated gene of interest, which is cloned into pDONR P5-P2 for MultiSite Gateway cloning. Primers are depicted as arrows, attB sites appear in blue, coding sequence is in red, and the point mutation appears as a green star.
F1 PCR mix:
F2 PCR mix:
34.5 μ L purifi ed water 3. Run 1 μ L of each PCR reaction on a gel with a calibrated ladder ( Fig. A2 ) to verify fragment size and estimate DNA concentration. 4. If correct, proceed to PCR fusion with the following caveats:
• Total DNA mass must not exceed 800 ng.
• Add fragments in equimolar amounts. Example: F1 is ~2500 bp and F2 is ~1000 bp, thus 480 ng of F1 and 320 ng of F2 were used ( Fig. A2 ).
PCR Fusion mix:
Thermocycler conditions: . PCR products separated on a 1% agarose gel (100 V, 25 min). Concentrations of F1 and F2 were both estimated at ~240 ng/ μ L. However, F1 is ~2500 bp and F2 is ~1000 bp. Thus, 2 μ L of PCR reaction F1 was combined with 1.33 μ L of PCR reaction F2 for the PCR fusion reaction.
5. Sequence a plasmid with the expected restriction fragment pattern to verify the mutation and the absence of PCR errors. The primers used to sequence the CESA5 entry clones are listed in Appendix 3. 6. To create an expression vector, clone the sequence-verifi ed plasmid along with a pDONR P1-P5r entry clone containing an epitope tag (available from the author) into pTHAct1Gate (available from Pierre-Francois Perroud, Washington University, St. Louis, Missouri, USA) using LR Clonase II Plus as described by the manufacturer (Life Technologies). 7. Transform competent E. coli with the LR reaction and incubate on the appropriate selective medium as in step 2. 8. Isolate plasmid DNA from four overnight cultures inoculated with single colonies as in step 3. 9. Digest 1 μ L of each plasmid prep with 2.5 units of Swa I in a 20-μ L reaction according the manufacturer's instructions (New England Biolabs) to screen for the expected restriction fragment pattern (2519-bp backbone plus the expression vector of approximately 10,000 bp). 10. Sequence a plasmid with the expected restriction fragment pattern to confi rm proper integration of both entry clones into the destination vector. Primer P395 (Appendix 3) was used for expression vectors containing CESA5 entry clones.
Expression vector preparation:

